Trial · NCT01994070
Chemical vs Electrical Cardioversion for Emergency Department Patients With Acute Atrial Fibrillation
NCT01994070, Phase 3, Completed, University of British Columbia
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Chemical vs Electrical Cardioversion for Emergency Department Patients With Acute Atrial Fibrillation. Trials, record NCT01994070. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01994070
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Chemical vs Electrical Cardioversion for Emergency Department Patients With Acute Atrial Fibrillation
- NCT number
- NCT01994070
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 86 participants, actual
- Lead sponsor
- University of British Columbia
- Conditions
- Atrial Fibrillation
- Interventions
- Electrical-first, Chemical-first
- First posted
- 2013-11-25
- Last updated
- 2015-06-11
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Length-of-stay | up to 12 hours | Length of stay is defined as the time from patient randomization to discharge from the emergency department. |
| Secondary | Adverse events | up to 12 hours after randomization | * Sentinel risk * Oxygen desaturation \> 60 seconds or \< 75% * Apnea \> 60 seconds * Shock * Cardiac arrest * Minor risk * Oxygen desaturation \< 60 seconds * Apnea \< 20 seconds * Airway obstruction * Failed sedation * Allergic reaction, no anaphylaxis * Bradycardia * Tachycardia * Hypotension * Hypertension * Ventricular arrhythmia * Seizure * Minimal risk * Vomiting / retching * Subclinical respiratory depression * Muscle rigidity * Hypersalivation * Paradoxical response * Recovery agitation * Prolonged recovery Note: All potential adverse events will be referred to a central safety committee. Members of this committee will be blinded to patient treatment group and blinded to 3- and 30-day outcomes. The central safety committee will determine whether an adverse event occurred and categorize the severity. |
| Other | Quality of life | 30 days | Patients will be contacted by telephone three and 30 days after the ED visit and asked quality of life questions based on the Short Form (SF)-8. The 30-day outcomes of stroke and death will also be assessed. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01994070
GET https://conductscience.org/api/trials/v1/NCT01994070/registered